Miiskin focuses on helping you monitor, understand, and manage your skin health through technology-driven tools and access to professional dermatology care.
The brand positions its offerings as support tools if you are more proactive about your skin health, whether you are keeping an eye on mole changes, managing acne, or monitoring cosmetic and aging-related concerns.
In the following review, we will take an overview of Miiskin’s offerings, the advantages it brings as a digital skin-health platform, the limitations you should be aware of, and what real consumer feedback shows about their experience with the brand.
As per the official website, Miiskin is a teledermatology brand and virtual care platform that connects you with independent, board-certified dermatologists across all 50 U.S. states.
The platform enables you to consult a dermatologist remotely, receive clinical evaluations for skin and hair concerns, and access prescription options that can be sent to your preferred local pharmacy or fulfilled through its partner compounding pharmacy, Foothills Pharmacy.
Miiskin covers multiple dermatology care categories, including acne (mild, moderate, and hormonal), wrinkles and anti-aging concerns, melasma and hyperpigmentation (such as sun spots and freckles), and hair loss. It also supports other visible skin conditions and offers pediatric dermatology through select specialists.
Instead of traditional product collections, the brand provides prescription-based options and personalized compounded formulas. Through its Foothills Pharmacy integration, you can order customized topical and oral medications directly within the platform, with most compounded skincare formulas typically priced around $48.99–$58.99 and specialized hair-growth formulas around $68.99. Oral medications generally range from $24.99–$38.99, depending on pill count.
Miiskin also emphasizes continuity of care by allowing you to choose your dermatologist and continue follow-ups with the same provider. Consultation fees generally range from about $55–$69 for new visits and $30–$39 for prescription renewals, with flexibility to use any pharmacy or opt for Foothills’ customized formulas with free delivery.
Miiskin offers Asynchronous Telehealth support by allowing you to submit your skin concerns, photos, and medical details through the platform so a board-certified dermatologist can review your case without the need for a live video visit. This model is said to be used for visible conditions such as mild, moderate, and hormonal acne, wrinkles and skin-texture concerns, melasma, hyperpigmentation and sun spots, hair loss, rosacea, eczema, psoriasis, and other treatable skin issues. You begin by starting a consultation, answering guided questions, uploading close-up images of the affected areas, and selecting your preferred pharmacy.
Once submitted, an independent dermatologist from the Miiskin Network evaluates your photos, history, and preferences, then provides a diagnosis and procedure plan and, when medically appropriate, prescribes medication. Your prescriptions can then be sent to a local pharmacy, or you can choose Miiskin’s integrated option through Foothills Pharmacy, where personalized compounded formulas and select hair-care formulations are delivered with free two-day shipping.
As per the official website, care is delivered only by board-certified dermatologists, ensuring clinical expertise and continuity with the same specialist over time. The network includes experienced clinicians such as Dr. Anne Allen, Dr. Trisha Khanna, Dr. Sarita Nori, Dr. Ryan Trowbridge, Dr. Amit Om, Dr. Anna Chacon, Dr. Eric Howell, and Dr. Craig Burkhart.
Miiskin’s Automatic Skin Imaging (AI Feature) allows you to capture consistent full-body skin photos, including both front and back views, to support ongoing monitoring of visible skin changes. The feature enables you to compare images side by side so they can notice new lesions, evolving marks, or changes in skin conditions that affect larger areas of the body. This helps you document progress between visits while giving providers a clearer visual context during asynchronous teledermatology assessments.
As part of Miiskin’s advanced skin imaging technology, Automatic Skin Imaging works in combination with supporting features such as Blurriness Detection, which prompts you to retake unclear close-up photos to improve image quality, and Mole Sizing, where the app uses a coin as a reference object to digitally calculate mole or lesion size over time. These capabilities enhance the accuracy of your submitted images and contribute to more reliable clinical review and procedure tracking within the Miiskin PRO platform.
Mole Sizing & Comparison is a feature in the Miiskin app that helps you estimate the absolute size of skin lesions, such as moles, and observe how their dimensions may change over time. Instead of relying only on standard photos, which can be misleading if the distance between the camera and the skin varies from one image to another, this feature uses a reference object of known size (typically a coin) placed next to the mole in the photo. The coin is automatically detected, and the app can auto-suggest a measurement length for the mole, while still allowing you to select and confirm the exact dimension you want to measure.
To support accurate images, Miiskin uses an augmented reality engine that identifies the coin and its angle in the frame, helping you position it correctly before capturing the photo. Mole Sizing can help you better understand whether a mole aligns with parts of the dermatology ABCDE framework by providing a clearer impression of a mole’s real-world size, especially the Diameter (D) criterion of being larger than 6 mm and the Evolution (E) criterion related to changes in size over time.
This feature is intended for personal monitoring only and is not a diagnostic or skin risk assessment tool. Miiskin advises you to consult a qualified doctor for any mole or lesion that meets the ABCDE warning signs. At present, the measurements are not recommended for clinical decision-making due to regulatory considerations, and professional clinicians are asked not to use the feature in medical settings. Mole Sizing has undergone internal testing and is released in beta mode for non-professional use while Miiskin gathers real-world feedback and continues improving the experience.
Miiskin functions as an online dermatology platform that provides virtual consultations through its mobile application and web interface. The brand states that you can address skin and hair concerns by submitting structured health information and photographs, which are then reviewed asynchronously by board-certified dermatologists. According to the platform, responses are typically delivered within 24 to 48 hours, without the need for live video appointments.
Miiskin highlights a defined consultation workflow designed for remote evaluation. You are prompted to select a specific concern, such as acne, eczema, rashes, or hair loss, and to upload several high-resolution images using guided capture instructions intended to support clinical review. The brand states that dermatologists assess these submissions, communicate recommendations through secure messaging, and may prescribe a procedure when clinically appropriate, all within the digital platform.
The company also claims that its online dermatology services are suited to non-urgent conditions, follow-up care, and ongoing monitoring. Features such as stored image histories and side-by-side image comparisons are presented as tools that help document progression over time and support continuity in care.
Miiskin offers access to independent, board-certified dermatologists as a central component of its online care model. The brand states that participating clinicians are medical doctors who have completed dermatology residency training, passed board certification examinations, and are licensed to practice in the user’s state. This framework is presented as ensuring that skin and hair consultations are reviewed by physicians with specialized dermatologic training rather than by non-physician providers.
The brand also highlights transparency around its clinician network by publicly listing participating dermatologists on its official site. Examples include Dr. Anne Allen, Dr. Trisha Khanna, Dr. Sarita Nori, Dr. Ryan Trowbridge, Dr. Amit Om, Dr. Anna Chacon, Dr. Eric Howell, and Dr. Craig Burkhart. These clinicians are described as independent practitioners who use the Miiskin platform to deliver virtual evaluations and issue prescriptions when clinically appropriate.
Miiskin supports continuity and provider choice by allowing you to select a preferred dermatologist and return to the same clinician for follow-up care. The system is designed to retain prior images, consultation notes, and plan history within a centralized dashboard, enabling clinicians to review earlier assessments and track progression over time. This approach is positioned as supporting more consistent and individualized clinical oversight.
Miiskin states that its mobile app provides guided, dermatoscope-like instructions for photographing skin areas, including recommendations on lighting, angle, distance, and scale. These prompts are intended to promote consistency across images taken at different times, which the brand supports for more reliable visual comparison.
Miiskin claims its tracking tools are designed for ongoing use rather than single-point documentation. Images of skin spots, rashes, or areas of hair change are stored chronologically within the app, enabling side-by-side comparison over time. This organized image history creates a visual timeline that may help you and clinicians observe changes or stability across successive check-ins.
The brand also claims that its skin tracking technology is integrated into clinical consultation workflows. Image histories and timelines can be securely shared with dermatologists during virtual consultations, allowing clinicians to reference past images when evaluating progression or planning follow-up.
Miiskin has a relatively modest volume of independent, third-party consumer reviews when compared with more widely adopted health and wellness applications. Publicly available data shows minimal presence on general consumer review platforms, with only a small number of reviews on Trustpilot, while feedback is more heavily concentrated within app store environments. The platform has approximately 1900 reviews on Google Play and around 1400 reviews on the Apple App Store, where overall ratings are generally favorable.
The distribution of reviews is narrow. Most feedback centers on app-specific considerations such as photo capture quality, pricing, and basic usability rather than broader evaluations of long-term outcomes or comparative performance. Mentions on forums such as Reddit are relatively infrequent and tend to be exploratory or cautionary rather than comprehensive reviews. This pattern reflects Miiskin’s clinical and teledermatology positioning, where adoption is often driven by medical need or clinician involvement rather than mass consumer discovery.
Direct Derm (First Derm) focuses on fast, anonymous online dermatology consultations reviewed directly by board-certified dermatologists, while Miiskin positions itself as an asynchronous telemedicine and skin-imaging platform that supports providers with advanced photo-based monitoring tools. First Derm emphasizes a human-only review model in which every case is evaluated by a dermatologist with more than 10 years of clinical experience, delivering likely condition identification, OTC recommendations, and next-step guidance within hours and always within 48 hours. In comparison, Miiskin centers its value on technology features such as blurriness detection, automatic full-body imaging, face-tracking photo diaries, and mole-sizing using a coin as a reference, enabling clinicians to review structured imaging data asynchronously or convert cases into video or in-person visits through the Miiskin PRO provider portal.
Another key difference lies in privacy and access. First Derm is described as the only fully anonymous online dermatology platform, requiring no account creation and allowing you to receive expert guidance without revealing your identity, with consultations starting at $34.95 for adults, teens, and children. Miiskin follows a standard telemedicine workflow where you and providers use accounts, and consultations are delivered by independent dermatologists on a cash-pay-only basis, with prescriptions routed through third-party pharmacies when medically appropriate.
The platforms also differ in how technology supports care. First Derm explicitly states that it is not an AI or machine-learning app and relies entirely on human dermatologists to review uploaded photos and patient descriptions. Miiskin integrates AI-assisted imaging capabilities to improve photo quality and measurement accuracy, prompting you to retake blurred close-ups and enabling side-by-side comparison of full-body photos to detect changes such as new lesions or expanding skin conditions.
First Derm provides episodic, case-based consultations without longitudinal progress-tracking tools, whereas Miiskin offers ongoing tracking features for procedure progress, facial changes, and mole size trends that can later be shared during follow-up care.
The platform First Derm prioritizes anonymity, speed, and expert guidance for immediate dermatology concerns, while Miiskin prioritizes imaging precision, structured documentation, and workflow support for clinicians delivering asynchronous dermatology care.
Miiskin and HoneyDew both focus on providing online dermatology services and claim to make professional skin services more accessible for you. However, they appear to be different in terms of continuity of care and their pricing structure.
HoneyDew focuses on providing procedure-centric online dermatology care, especially for acne and related conditions, while Miiskin functions primarily as a teledermatology and skin-imaging platform that connects you with independent dermatologists and supports asynchronous consultations.
HoneyDew highlights unlimited online care delivered by licensed dermatology providers, including board-certified dermatologists, nurse practitioners, and physician assistants, with a strong emphasis on clinically proven acne support such as standard and low-dose options, along with custom compounds and other FDA-approved options. In comparison, Miiskin offers broader condition coverage beyond acne, supporting concerns like hair loss, rosacea, hyperpigmentation, fungal infections, anti-aging, pediatric dermatology, eczema, psoriasis, and rashes, while prescriptions, if medically appropriate, are routed to third-party or partner pharmacies.
HoneyDew operates as a membership-based care model with pricing options such as $39 per month (with a three-month minimum) or $299 yearly, offering unlimited consultations, prescription management, progress tracking, and ongoing support from a dedicated care team. Miiskin instead follows a cash-pay, per-consultation structure, with consultation costs typically ranging from $30 to $59, allowing you to choose your preferred dermatologist and pharmacy, including the option to use Foothills Pharmacy for customized compounded formulations with free shipping when ordered through the platform.
HoneyDew emphasizes an interactive procedure journey built around video consultations, home-delivered or pharmacy-filled prescriptions, photo-based progress tracking, and around-the-clock access to the care team for refills and support. Miiskin, on the other hand, places a stronger focus on technology-driven imaging features that enhance clinical review, including blurriness detection for close-up lesion photos, face-tracking photo diaries for procedure progress monitoring, automatic full-body skin imaging for change detection, and mole sizing using AI with a coin as a reference object.
HoneyDew frames its mission around making proven acne options more accessible and improving outcomes through structured follow-ups and evidence-based care, while Miiskin positions itself as a teledermatology ecosystem that supports asynchronous evaluations and integrates provider workflows through its PRO portal for clinicians.
HoneyDew focuses on continuous, program-style medical management for acne and skin conditions within a subscription framework, while Miiskin features flexible, on-demand consultations, advanced skin-imaging capabilities, pharmacy integration for compounded options, and a technology-supported approach to remote dermatology care.
To evaluate MiiSkin, we reviewed customer feedback on Trustpilot, where the brand currently holds a 2.8 rating based on 6+ reviews. Several users stated that the brand options or prescriptions did not match what they specifically requested. These responses suggest similar themes, including concerns about refunds, communication gaps, and dissatisfaction with the overall value for the money spent.
At the same time, there are a few positive experiences that emphasize strengths in the platform’s virtual care model. Some customers praise MiiSkin for being easy to use and highly responsive despite operating entirely online, noting a satisfactory consultation experience and recommending the service to others. The brand also replies to some negative reviews to clarify that prescriptions are written by independent dermatologists and that platform payments cover consultation fees rather than medications, which reflects an effort to explain its service structure and address misunderstandings.
MiiSkin appears to provide a convenient teledermatology option that works well for a small number of users who value quick, virtual access to care, but consistency in user experience remains a significant concern. Recurring complaints about unmet expectations, lack of clarity around prescriptions and costs, and difficulty resolving issues outweigh the limited positive feedback.
Miiskin is a digital health brand with a primary focus on technology-supported skin health monitoring. Its app helps you track changes in moles, spots, and other visible skin concerns through photo-based documentation, side-by-side image comparison, skin-check reminders, and secure cloud storage. It also offers optional teledermatology services that connect you with independent board-certified dermatologists for virtual consultations and prescription care.
The brand holds a 4.4 rating based on 13+ reviews on TenereTeam, indicating generally positive feedback but from a relatively small review base. This limited volume means the rating should be interpreted cautiously, as it may not fully represent broader user experiences.
However, at the time of writing this review, Miiskin does not have a profile on the Better Business Bureau platform. However, it is not unusual for international or digital-first healthcare companies.
Miiskin presents itself as a legitimate and evolving skin-health and teledermatology platform with a clear focus on skin monitoring and remote dermatology access. At the same time, the small number of verified reviews and the absence of a BBB profile mean potential users should review available feedback carefully and consider the app as a complementary tool rather than a substitute for in-person medical care when necessary.
Miiskin may help you access prescription-based care for non-urgent skin and hair concerns through remote consultations, asynchronous clinical evaluations, and image-tracking features. The platform focuses on conditions such as acne, pigmentation concerns, aging-related skin issues, rashes, and hair loss, with some clinicians also supporting pediatric cases.
At the same time, the platform has some limitations you should carefully consider. Miiskin is most suitable for mild to moderate conditions and does not replace in-person care for suspicious or rapidly changing lesions, severe inflammatory conditions, procedural needs, biopsies, or situations that require physical examination and dermoscopic evaluation.
Diagnostic accuracy may be influenced by lighting, photo clarity, and user-submitted information. Independent feedback outside app-store environments remains relatively limited, which makes long-term outcome assessment less transparent.
If you decide to use Miiskin, you should take certain precautions. Avoid using remote consultations for urgent or high-risk symptoms that require immediate in-person review. Provide clear photographs and a complete medical history, including previous procedures, allergies, medications, and health conditions, as these factors can influence clinical decisions.
Contact us at [email protected] or follow @leafsnap on Twitter! View our Privacy Policy.
